![](/img/cover-not-exists.png)
Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo‐controlled, phase I study in healthy volunteers
Gan, Li‐Ming, Lagerström‐Fermér, Maria, Ericsson, Hans, Nelander, Karin, Lindstedt, Eva‐Lotte, Michaëlsson, Erik, Kjaer, Magnus, Heijer, Maria, Whatling, Carl, Fuhr, RainardVolume:
85
Language:
english
Journal:
British Journal of Clinical Pharmacology
DOI:
10.1111/bcp.13855
Date:
April, 2019
File:
PDF, 975 KB
english, 2019